Today: 11 June 2026
SLB stock in focus before the open as oil slips on Venezuela upheaval and earnings near
5 January 2026
1 min read

SLB stock in focus before the open as oil slips on Venezuela upheaval and earnings near

NEW YORK, Jan 5, 2026, 04:31 ET — Premarket

  • SLB was indicated near $40.20 in premarket, roughly flat from Friday’s close.
  • Oil prices eased after weekend political shock in Venezuela, but traders pointed to ample global supply.
  • Investors are positioning ahead of SLB’s Jan. 23 quarterly results and outlook for 2026 spending.

SLB shares were indicated around $40.20 in premarket trading on Monday, little changed from Friday’s close, as a dip in oil prices kept the energy complex on edge ahead of the U.S. open.

That matters now because SLB, the world’s biggest oilfield services provider, tends to move with expectations for drilling and well-completion activity. Those expectations can shift quickly when crude prices swing, since producers often adjust budgets when prices weaken.

The stock is also heading into a key catalyst: SLB is due to report fourth-quarter and full-year 2025 results later this month, when it will update investors on demand, pricing and cash returns such as dividends and buybacks. Guidance is the company’s outlook, and it often drives the next leg in the share move more than the quarter itself.

Oil prices slipped even after the weekend’s political shock in Venezuela, with traders pointing to ample supply and OPEC+ holding output steady. “All bets are off in a chaotic change of power scenario like what occurred in Libya or Iraq,” Helima Croft, RBC Capital’s head of commodities research, said. Reuters

SLB enters Monday after a strong previous session: the stock rose about 4.7% on Friday, matching gains in rival oilfield services names including Halliburton and outpacing Baker Hughes, as the sector rebounded with the broader market.

Company-specific news has been quieter in recent days, but SLB has pointed to long-cycle international work as a growth driver. In late December, the company said Saudi Aramco awarded it a five-year contract tied to unconventional gas development, covering “stimulation” work — the hydraulic fracturing and related services used to boost output from tight reservoirs. SLB

The next read-through for traders will come on Jan. 23, when SLB is scheduled to release results before the bell and then host a conference call. Investors will be listening for any shift in comments on North America activity, international pricing and whether customers are tightening spending plans into 2026.

Technically, the shares are back around the $40 level after Friday’s surge, with the stock still below its 52-week high and well above its 52-week low. Traders often treat round numbers such as $40 as near-term pivot points, especially heading into earnings.

But the setup cuts both ways. If crude continues to slide on expectations of oversupply, producers may lean harder on service providers for pricing concessions — a risk for margins — even as geopolitical shocks keep the market headline-driven.

Stock Market Today

  • Wall Street Gains on AI Stock Rally Amid Inflation and Middle East Tensions
    June 11, 2026, 11:16 AM EDT. Wall Street recovered some weekly losses Thursday as artificial intelligence (AI) stocks rebounded, led by chipmakers like Marvell Technology (+5.5%), Intel (+7.8%), and Applied Materials (+7.5%). The S&P 500 rose 0.5%, Dow Jones 0.7%, and Nasdaq 0.7%. Despite market gains, concerns about elevated AI valuations persist, while Oracle shares fell 11.1% after revealing plans to raise $40 billion to fund AI investments. Oil prices remained steady despite rising tensions in the Iran conflict, with Brent crude at $92.64 and U.S. crude at $90.29 per barrel. Meanwhile, wholesale inflation in the U.S. exceeded expectations in May, prompting the European Central Bank to raise interest rates, signaling global inflationary pressures.

Latest articles

Theriva Biologics Pops on VCN-01 Study Results, Gets Traders’ Attention

Theriva Biologics Pops on VCN-01 Study Results, Gets Traders’ Attention

11 June 2026
TOVX soared 74.6% to $0.4252 after Theriva Biologics published Phase 1 VCN-01 data showing survival and biomarker signals in head-and-neck cancer, but the jump was not due to drug approval or revenue; investors face ongoing financing, dilution, and clinical-trial execution risks, with the company’s cash runway only into Q1 2027 and substantial doubt about its ability to continue as a going concern without new capital.
Trulieve Stock Turns Heads on NYSE After $50 Million Buyback

Trulieve Stock Turns Heads on NYSE After $50 Million Buyback

11 June 2026
Trulieve began NYSE trading as TRLV this week after moving from OTC/CSE, authorized a buyback of up to $50 million or 8.5 million shares, and closed its first NYSE session at $11.50, down 0.43%, before trading near $11.78 early Thursday, as investors weigh whether the uplisting and buyback will boost demand amid ongoing federal cannabis policy uncertainty.
BAE Systems shares jump nearly 5% as Venezuela shock lifts European defense stocks
Previous Story

BAE Systems shares jump nearly 5% as Venezuela shock lifts European defense stocks

NuScale Power stock jumps 16% as House sets ‘New Nuclear Era’ hearing — what’s next for SMR
Next Story

NuScale Power stock jumps 16% as House sets ‘New Nuclear Era’ hearing — what’s next for SMR

Go toTop